The super-sized gathering of the biopharma universe known as JPM is important, but it’s not going to make or break the year ...

Broadcast Retirement Network's Jeffrey Snyder discusses the state of investment in the life sciences with scientist and ...

The University of Pennsylvania, biotech firm BioNTech, and Osage University Partners, a venture capital firm in Bala Cynwyd, ...

Stoke Therapeutics and the FDA were unable to reach agreement on an expedited submission for the company’s severe epilepsy ...

Researchers at a university in England have received funding to investigate how Campylobacter outcompetes other bacteria and ...

Albuquerque-based EquiSeq is a biotech company developing DNA tests for inherited muscle diseases, like muscle integrity ...

Focused on therapies for endocrine and oncologic conditions, this biotech reported significant insider selling in its latest ...

Atlantic County Institute of Technology (ACIT) is in the final group of county vocational-technical schools to complete its ...

Focused on precision therapies for rare diseases, this biotech firm reported a significant insider sale amid a year of sharp ...

This clinical-stage biotech specializing in blood disorders reported a notable insider sale amid strong recent stock performance.

A key US approval is great news for this company. The post Which biotech company's shares have rocketed to a new high on good ...

This biotech innovator in antibody therapies for inflammatory bowel disease reported a notable insider sale, according to a recent SEC filing.